CVSA
Covista Inc.
Company overview
- Market capitalization
- $4.00B
- Employees
- 4,703
- Latest publication
- 2026-09-29
About Covista Inc.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. has a strategic collaboration agreement with Advocate Health to expand access to nursing education and build a direct pipeline of practice-ready nurses across the communities Advocate Health serves. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Financial statements
Income Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20182018-06-30 · USD | FY 20172017-06-30 · USD | FY 20152015-06-30 · USD | FY 20142014-06-30 · USD | FY 20122012-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,954,085,000USD | 1,788,290,000USD | 1,584,652,000USD | 1,235,778,000USD | 1,207,909,000USD | 1,909,943,000USD | 1,923,371,000USD | 2,089,781,000USD |
| Cost Of Revenue | 833,660,000USD | 771,430,000USD | 698,548,000USD | 624,850,000USD | 638,245,000USD | 958,035,000USD | 935,126,000USD | 944,524,000USD |
| Gross Profit | 1,120,425,000USD | 1,016,860,000USD | 886,104,000USD | 610,928,000USD | 569,664,000USD | 951,908,000USD | 988,245,000USD | 1,145,257,000USD |
| Selling General Administrative | 730,720,000USD | 423,712,000USD | 386,565,000USD | 262,807,000USD | 293,443,000USD | 444,085,000USD | 727,870,000USD | 808,400,000USD |
| Total Operating Expenses | 737,049,000USD | 675,318,000USD | 669,050,000USD | 380,446,000USD | 434,166,000USD | 752,978,000USD | 776,180,000USD | 839,518,000USD |
| Operating Income | 383,376,000USD | 341,542,000USD | 217,054,000USD | 230,482,000USD | 135,498,000USD | 201,603,000USD | 212,065,000USD | 305,739,000USD |
| Total Other Income Expense Net | -38,257,000USD | -43,028,000USD | -53,117,000USD | -31,937,000USD | -4,933,000USD | -47,943,000USD | -32,698,000USD | -99,601,000USD |
| Interest Expense | 45,435,000USD | 52,318,000USD | 63,659,000USD | 14,620,000USD | 9,144,000USD | 5,313,000USD | 3,632,000USD | 2,612,000USD |
| Income Before Tax | 345,119,000USD | 298,514,000USD | 163,937,000USD | 198,545,000USD | 130,565,000USD | 153,660,000USD | 179,367,000USD | 206,138,000USD |
| Income Tax Expense | 77,744,000USD | 65,837,000USD | 26,224,000USD | 84,102,000USD | 9,594,000USD | 18,537,000USD | 27,699,000USD | 63,757,000USD |
| Discontinued Operations | -15,809,000USD | — | — | -80,146,000USD | 2,309,000USD | 5,576,000USD | -16,957,000USD | — |
| Net Income | 251,566,000USD | 232,677,000USD | 136,777,000USD | 33,769,000USD | 122,283,000USD | 139,899,000USD | 134,032,000USD | 141,565,000USD |
| Selling And Marketing Expenses | — | 247,400,000USD | 227,900,000USD | 64,900,000USD | 75,600,000USD | 264,200,000USD | — | — |
| Interest Income | — | 8,216,000USD | 9,177,000USD | 5,827,000USD | 4,925,000USD | 3,250,000USD | — | — |
| Net Interest Income | — | -44,102,000USD | -63,659,000USD | -8,793,000USD | -4,219,000USD | — | — | — |
| Tax Provision | — | 65,837,000USD | 26,224,000USD | 84,102,000USD | 10,420,000USD | 18,537,000USD | — | — |
| Net Income From Continuing Ops | — | 232,677,000USD | 137,713,000USD | 114,443,000USD | 123,280,000USD | 135,123,000USD | 151,668,000USD | 142,381,000USD |
| Ebit | — | 342,845,000USD | 271,639,000USD | 230,482,000USD | 200,621,000USD | 201,603,000USD | 212,065,000USD | 305,739,000USD |
| Ebitda | — | 427,310,000USD | 346,959,000USD | 283,306,000USD | 257,595,000USD | 292,159,000USD | 301,882,000USD | 394,428,000USD |
| Depreciation And Amortization | — | 84,465,000USD | 75,320,000USD | 52,824,000USD | 56,974,000USD | 90,556,000USD | 89,817,000USD | 88,689,000USD |
| Reconciled Depreciation | — | 84,465,000USD | 107,961,000USD | 52,824,000USD | 84,061,000USD | — | — | — |
| Unclassified Operating Expenses | — | — | 54,585,000USD | 52,739,000USD | 65,123,000USD | 44,693,000USD | 48,310,000USD | 31,118,000USD |
| Research Development | — | — | — | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Operating Income Net Other | — | — | — | -138,000USD | -694,000USD | -3,250,000USD | -1,901,000USD | 1,901,000USD |
| Minority Interest | — | — | — | 528,000USD | 997,000USD | 800,000USD | 679,000USD | 816,000USD |
| Net Income Applicable To Common Shares | — | — | — | 33,769,000USD | 122,283,000USD | 139,899,000USD | 134,032,000USD | 141,565,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Quarterly
| Metric | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q1 20252024-09-30 · USD | Q3 20242024-03-31 · USD | Q1 20242023-09-30 · USD | Q3 20232023-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 503,385,000USD | 462,288,000USD | 457,106,000USD | 466,055,000USD | 417,400,000USD | 412,658,000USD | 368,845,000USD | 369,082,000USD |
| Cost Of Revenue | 205,425,000USD | 200,767,000USD | 198,930,000USD | 199,869,000USD | 185,995,000USD | 175,321,000USD | 168,618,000USD | 165,820,000USD |
| Gross Profit | 297,960,000USD | 261,521,000USD | 258,176,000USD | 266,185,999USD | 231,405,000USD | 237,337,000USD | 200,227,000USD | 203,262,000USD |
| Selling General Administrative | 182,791,000USD | 175,734,000USD | 66,537,000USD | 175,167,000USD | 159,073,000USD | 156,689,000USD | 166,095,000USD | 144,526,000USD |
| Unclassified Operating Expenses | 4,055,000USD | — | 114,714,000USD | — | 2,094,000USD | 14,492,000USD | 5,938,000USD | — |
| Total Operating Expenses | 186,846,000USD | 176,044,000USD | 181,251,000USD | 175,677,000USD | 161,167,000USD | 175,612,000USD | 172,033,000USD | 143,833,000USD |
| Operating Income | 111,114,000USD | 85,477,000USD | 76,925,000USD | 90,509,000USD | 70,238,000USD | 61,725,000USD | 28,194,000USD | 59,429,000USD |
| Interest Income | 1,574,000USD | 1,806,000USD | 1,705,000USD | 2,072,000USD | 2,033,000USD | 2,165,000USD | 2,661,000USD | 3,152,000USD |
| Interest Expense | 10,917,000USD | 11,090,000USD | 10,853,000USD | 13,074,000USD | 14,482,000USD | 16,559,999USD | 15,657,000USD | 14,457,000USD |
| Net Interest Income | -9,343,000USD | -9,284,000USD | -9,148,000USD | -11,002,000USD | -12,449,000USD | -14,395,000USD | -12,996,000USD | -14,457,000USD |
| Income Before Tax | 101,901,000USD | 76,873,000USD | 68,583,000USD | 79,333,000USD | 58,402,000USD | 48,036,000USD | 14,751,000USD | 48,952,000USD |
| Income Tax Expense | 25,828,000USD | 15,811,000USD | 14,121,000USD | 18,539,000USD | 12,157,000USD | 10,595,000USD | 2,792,000USD | 389,000USD |
| Tax Provision | 25,730,000USD | 15,811,000USD | 14,121,000USD | 18,539,000USD | 12,157,000USD | 10,595,000USD | 2,792,000USD | 389,000USD |
| Net Income | 76,376,000USD | 61,832,000USD | 54,212,000USD | 60,832,000USD | 46,165,000USD | 36,821,000USD | 10,646,000USD | 45,869,000USD |
| Net Income From Continuing Ops | 76,171,000USD | 61,062,000USD | 54,462,000USD | 60,794,000USD | 46,245,000USD | 37,441,000USD | 11,959,000USD | 48,563,000USD |
| Ebit | 115,169,000USD | 85,787,000USD | 77,313,000USD | 97,461,000USD | 72,332,000USD | 80,648,000USD | 52,632,000USD | 58,736,000USD |
| Ebitda | 128,928,000USD | 98,888,000USD | 90,553,000USD | 110,540,000USD | 84,940,000USD | 99,432,000USD | 72,647,000USD | 83,125,000USD |
| Depreciation And Amortization | 13,759,000USD | 13,101,000USD | 13,240,000USD | 13,079,000USD | 12,608,000USD | 18,784,000USD | 20,015,000USD | 24,389,000USD |
| Reconciled Depreciation | 20,954,000USD | 20,317,000USD | 20,453,000USD | 24,317,000USD | 19,556,000USD | 27,043,000USD | 29,220,000USD | 33,705,000USD |
| Total Other Income Expense Net | -9,213,000USD | -8,604,000USD | -8,342,000USD | -11,176,000USD | -11,836,000USD | -13,689,000USD | -13,443,000USD | -10,477,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 4,431,000USD | — | — |
| Discontinued Operations | — | — | — | — | — | — | -1,313,000USD | -2,694,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | 10,646,000USD | 45,869,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 3,980,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q4 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,012,708,000USD | 2,737,427,000USD | 2,614,713,000USD | 2,867,463,000USD | 2,752,352,000USD | 2,789,759,000USD | 2,722,955,000USD | 2,817,707,000USD |
| Cash And Equivalents | 406,316,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 652,441,000USD | 403,755,000USD | 302,982,000USD | 567,217,000USD | 416,190,000USD | 450,343,000USD | 407,085,000USD | 516,914,000USD |
| Other Current Assets | 75,126,000USD | 78,992,000USD | 83,853,000USD | 107,689,000USD | 70,400,000USD | 68,354,000USD | 66,154,000USD | 80,606,999USD |
| Other Non Current Assets | 137,738,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 1,566,523,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 596,820,000USD | 580,447,000USD | 442,885,000USD | 576,616,000USD | 507,927,000USD | 540,569,000USD | 384,554,000USD | 551,309,000USD |
| Other Current Liabilities | 94,364,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 42,325,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,446,185,000USD | 1,364,105,000USD | 1,378,796,000USD | 1,457,624,000USD | 1,433,625,000USD | 1,432,713,000USD | 1,438,910,000USD | 1,389,952,000USD |
| Total Equity Including Noncontrolling Interest | 1,446,185,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 5,100,000USD | 3,825,000USD | — | — | — | — | — | — |
| Long Term Debt | 657,750,000USD | 495,644,000USD | 504,282,000USD | 553,152,000USD | 552,669,000USD | 552,186,000USD | 649,924,000USD | 649,318,000USD |
| Deferred Revenue | 259,125,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 507,013,000USD | 478,051,000USD | 455,519,000USD | 447,119,000USD | 447,325,000USD | 449,229,000USD | 434,678,000USD | 416,424,000USD |
| Goodwill | 961,262,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 754,254,000USD | 757,059,000USD | 759,864,000USD | 762,669,000USD | 765,474,000USD | 768,279,000USD | 771,084,000USD | 773,889,000USD |
| Accounts Payable | 124,763,000USD | 97,261,000USD | 103,103,000USD | 104,576,000USD | 105,017,000USD | 98,709,000USD | 66,920,000USD | 91,421,000USD |
| Short Term Debt | 34,799,000USD | 39,055,000USD | 33,917,000USD | 34,392,000USD | 35,159,000USD | 34,882,000USD | 32,633,000USD | 32,266,000USD |
| Common Stock | 848,000USD | 847,000USD | 847,000USD | 847,000USD | 839,000USD | 839,000USD | 839,000USD | 838,000USD |
| Retained Earnings | 3,029,140,000USD | 2,957,419,000USD | 2,915,782,000USD | 2,839,406,000USD | 2,777,574,000USD | 2,723,362,000USD | 2,662,530,000USD | 2,586,674,000USD |
| Accumulated Other Comprehensive Income | -2,227,000USD | -2,227,000USD | -2,226,999USD | -2,226,999USD | -2,226,999USD | -2,227,000USD | -2,227,000USD | -2,226,999USD |
| Total Liab | — | 1,373,322,000USD | 1,235,917,000USD | 1,409,839,000USD | 1,318,727,000USD | 1,357,046,000USD | 1,284,045,000USD | 1,427,755,000USD |
| Other Current Liab | — | 167,939,000USD | 305,865,000USD | 437,648,000USD | 367,751,000USD | 406,978,000USD | 285,001,000USD | 427,622,000USD |
| Capital Stock | — | 847,000USD | 847,000USD | 847,000USD | 839,000USD | 839,000USD | 839,000USD | 838,000USD |
| Good Will | — | 961,262,000USD | 961,262,000USD | 961,262,000USD | 961,262,000USD | 961,262,000USD | 961,262,000USD | 961,262,000USD |
| Cash | — | 148,839,000USD | 56,281,000USD | 264,690,999USD | 199,601,000USD | 219,017,000USD | 193,958,000USD | 264,798,000USD |
| Cash And Short Term Investments | — | 148,839,000USD | 56,281,000USD | 264,690,999USD | 199,601,000USD | 219,017,000USD | 193,958,000USD | 264,798,000USD |
| Current Deferred Revenue | — | 276,192,000USD | 180,429,000USD | 322,867,000USD | 214,091,000USD | 247,811,000USD | 171,523,000USD | 290,571,000USD |
| Net Debt | — | 587,455,000USD | 673,271,000USD | 511,259,000USD | 574,399,000USD | 561,511,000USD | 670,650,000USD | 578,543,000USD |
| Short Long Term Debt Total | — | 736,294,000USD | 729,552,000USD | 775,950,000USD | 774,000,000USD | 780,528,000USD | 864,608,000USD | 843,341,000USD |
| Net Receivables | — | 175,924,000USD | 162,848,000USD | 194,837,000USD | 146,189,000USD | 162,972,000USD | 146,973,000USD | 171,509,000USD |
| Property Plant Equipment Gross | — | 850,502,000USD | 816,762,000USD | 797,912,000USD | 789,069,000USD | 781,426,000USD | 771,776,000USD | 745,473,000USD |
| Common Stock Shares Outstanding | — | 34,782,000shares | 36,230,000shares | 37,057,000shares | 37,584,000shares | 38,233,000shares | 38,401,000shares | 39,109,000shares |
| Non Current Assets Total | — | 2,333,672,000USD | 2,311,731,000USD | 2,300,246,000USD | 2,336,162,000USD | 2,339,416,000USD | 2,315,870,000USD | 2,300,793,000USD |
| Non Current Liabilities Total | — | 792,874,999USD | 793,032,000USD | 833,223,000USD | 810,800,000USD | 816,477,000USD | 899,491,000USD | 876,446,000USD |
| Non Current Liabilities Other | — | 36,905,000USD | 40,582,000USD | 38,352,000USD | 40,103,000USD | 37,242,000USD | 35,149,000USD | 35,023,000USD |
| Non Currrent Assets Other | — | 115,258,000USD | 135,086,000USD | 129,196,000USD | 162,101,000USD | 160,646,000USD | 148,846,000USD | 149,218,000USD |
| Net Working Capital | — | -176,692,000USD | -139,903,000USD | -9,399,000USD | -91,737,000USD | -90,226,000USD | 22,531,000USD | -34,395,000USD |
| Unclassified Non Current Liabilities | — | 260,325,999USD | 248,168,000USD | 241,719,000USD | 218,028,000USD | 227,049,000USD | 214,418,000USD | 192,105,000USD |
| Unclassified Equity | — | -1,592,781,000USD | -1,536,453,001USD | -1,381,249,001USD | -1,343,400,001USD | -1,290,100,000USD | -1,223,071,000USD | -1,196,171,001USD |
| Unclassified Current Liabilities | — | — | -180,429,000USD | -322,867,000USD | -214,091,000USD | -247,811,000USD | -171,523,000USD | -290,571,000USD |
| Short Term Investments | — | — | — | 13,500,000USD | 12,800,000USD | 11,900,000USD | 12,800,000USD | 12,900,000USD |
| Unclassified Current Assets | — | — | — | -13,499,999USD | -12,800,000USD | -11,900,000USD | -12,800,000USD | -12,899,999USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,012,708,000USD | 2,752,352,000USD | 2,741,417,000USD | 2,810,541,000USD | 3,030,240,000USD | 3,084,843,000USD | 2,228,687,000USD | 2,242,696,000USD |
| Cash And Equivalents | 406,316,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 652,441,000USD | 416,190,000USD | 418,085,000USD | 480,297,000USD | 557,104,000USD | 1,514,953,000USD | 692,766,000USD | 504,700,000USD |
| Other Current Assets | 75,126,000USD | 70,400,000USD | 71,946,000USD | 105,354,000USD | 128,496,000USD | 995,535,000USD | 105,208,000USD | 233,538,000USD |
| Other Non Current Assets | 137,738,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 1,566,523,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 596,820,000USD | 507,927,000USD | 487,657,000USD | 431,203,000USD | 423,647,000USD | 408,807,000USD | 345,983,000USD | 311,631,000USD |
| Other Current Liabilities | 94,364,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 42,325,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,446,185,000USD | 1,433,625,000USD | 1,369,135,000USD | 1,457,336,000USD | 1,491,386,000USD | 1,301,070,000USD | 1,310,420,999USD | 1,391,530,000USD |
| Total Equity Including Noncontrolling Interest | 1,446,185,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 5,100,000USD | — | — | — | — | 3,000,000USD | 3,000,000USD | 3,000,000USD |
| Long Term Debt | 657,750,000USD | 552,669,000USD | 648,712,000USD | 695,077,000USD | 838,908,000USD | 1,067,711,000USD | 286,115,000USD | 398,094,000USD |
| Deferred Revenue | 259,125,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 507,013,000USD | 447,325,000USD | 425,279,000USD | 419,326,000USD | 467,921,000USD | 451,057,000USD | 461,037,000USD | 283,433,000USD |
| Goodwill | 961,262,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 754,254,000USD | 765,474,000USD | 776,694,000USD | 812,338,000USD | 873,577,000USD | 137,500,000USD | 287,514,000USD | 297,989,000USD |
| Accounts Payable | 124,763,000USD | 105,017,000USD | 102,626,000USD | 81,812,000USD | 57,140,000USD | 42,421,000USD | 46,484,000USD | 53,385,000USD |
| Short Term Debt | 34,799,000USD | 35,159,000USD | 31,429,000USD | 37,673,000USD | 50,781,000USD | 56,991,000USD | 54,644,000USD | 3,000,000USD |
| Common Stock | 848,000USD | 839,000USD | 832,000USD | 822,000USD | 818,000USD | 811,000USD | 807,000USD | 801,000USD |
| Retained Earnings | 3,029,140,000USD | 2,777,574,000USD | 2,540,509,000USD | 2,403,750,000USD | 2,310,396,000USD | 2,005,105,000USD | 1,927,568,000USD | 2,012,902,000USD |
| Accumulated Other Comprehensive Income | -2,227,000USD | -2,226,999USD | -2,227,000USD | -2,226,999USD | -2,227,000USD | -7,365,000USD | -9,054,999USD | -137,289,999USD |
| Total Liab | — | 1,318,727,000USD | 1,372,282,000USD | 1,353,205,000USD | 1,538,854,000USD | 1,781,983,000USD | 915,414,000USD | 841,623,000USD |
| Other Current Liab | — | 367,751,000USD | 353,602,000USD | 311,718,000USD | 315,726,000USD | 309,395,000USD | 244,855,000USD | 255,246,000USD |
| Capital Stock | — | 839,000USD | 832,000USD | 822,000USD | 818,000USD | 811,000USD | 807,000USD | 801,000USD |
| Good Will | — | 961,262,000USD | 961,262,000USD | 961,262,000USD | 961,262,000USD | 310,210,000USD | 686,214,000USD | 687,256,000USD |
| Cash | — | 199,601,000USD | 219,306,000USD | 272,194,000USD | 346,973,000USD | 476,377,000USD | 500,516,000USD | 204,202,000USD |
| Cash And Short Term Investments | — | 199,601,000USD | 219,306,000USD | 272,194,000USD | 346,973,000USD | 476,377,000USD | 500,516,000USD | 204,202,000USD |
| Current Deferred Revenue | — | 214,091,000USD | 185,272,000USD | 153,871,000USD | 149,810,000USD | 149,810,000USD | 91,589,000USD | 95,944,000USD |
| Net Debt | — | 574,399,000USD | 628,547,000USD | 623,997,000USD | 719,761,000USD | 824,291,000USD | 26,675,000USD | 196,892,000USD |
| Short Long Term Debt Total | — | 774,000,000USD | 847,853,000USD | 896,191,000USD | 1,066,734,000USD | 1,300,668,000USD | 527,191,000USD | 401,094,000USD |
| Short Term Investments | — | 12,800,000USD | 13,200,000USD | 12,500,000USD | 17,800,000USD | 20,600,000USD | 8,968,000USD | 8,680,000USD |
| Net Receivables | — | 146,189,000USD | 126,833,000USD | 102,749,000USD | 81,635,000USD | 43,041,000USD | 87,042,000USD | 66,959,999USD |
| Property Plant Equipment Gross | — | 789,069,000USD | 751,558,000USD | 772,027,000USD | 467,921,000USD | 466,180,000USD | 461,037,000USD | 364,683,000USD |
| Common Stock Shares Outstanding | — | 38,334,000shares | 40,307,000shares | 45,600,000shares | 48,388,000shares | 51,645,000shares | 54,094,000shares | 59,330,000shares |
| Non Current Assets Total | — | 2,336,162,000USD | 2,323,332,000USD | 2,330,244,000USD | 2,473,136,000USD | 1,569,890,000USD | 1,535,921,000USD | 1,737,996,000USD |
| Non Current Liabilities Total | — | 810,800,000USD | 884,625,000USD | 922,002,000USD | 1,115,207,000USD | 1,373,176,000USD | 569,431,000USD | 529,992,000USD |
| Non Current Liabilities Other | — | 40,103,000USD | 38,675,000USD | 200,857,000USD | 242,119,000USD | 79,612,000USD | 82,309,000USD | 102,472,000USD |
| Non Currrent Assets Other | — | 162,101,000USD | 160,097,000USD | 137,318,000USD | 170,376,000USD | 671,123,000USD | 101,156,000USD | 469,318,000USD |
| Net Working Capital | — | -91,737,000USD | -69,572,000USD | 47,336,000USD | 138,512,000USD | 1,106,146,000USD | 346,783,000USD | 193,069,000USD |
| Unclassified Current Assets | — | -12,800,000USD | -13,200,001USD | -13,886,000USD | -17,800,000USD | -20,600,000USD | -8,968,001USD | -8,680,000USD |
| Unclassified Current Liabilities | — | -214,091,000USD | -185,272,000USD | -153,871,000USD | -149,810,000USD | -152,810,000USD | -94,589,000USD | -98,944,000USD |
| Unclassified Non Current Liabilities | — | 218,028,000USD | 197,238,000USD | -63,484,000USD | -82,002,000USD | 117,748,000USD | 92,207,000USD | -131,898,000USD |
| Unclassified Equity | — | -1,343,400,001USD | -1,170,811,000USD | -945,831,001USD | -818,419,000USD | 519,015,000USD | 503,626,998USD | 485,259,999USD |
| Inventory | — | — | 1USD | 1,386,000USD | — | — | 1USD | 1USD |
| Deferred Long Term Liab | — | — | — | 26,068,000USD | 25,554,000USD | 1,502,000USD | 1,516,000USD | 29,426,000USD |
| Other Liab | — | — | — | 63,484,000USD | 90,628,000USD | 106,603,000USD | 107,284,000USD | 131,898,000USD |
| Other Assets | — | — | — | 125,203,000USD | 170,376,000USD | 110,080,000USD | 101,156,000USD | 80,765,000USD |
| Net Tangible Assets | — | — | — | -316,264,000USD | -329,772,000USD | 338,447,000USD | 336,693,000USD | 98,933,000USD |
| Unclassified Non Current Assets | — | — | — | -125,203,000USD | -170,376,000USD | -110,080,000USD | -101,156,000USD | -80,765,000USD |
| Treasury Stock | — | — | — | — | — | -1,217,307,000USD | -1,113,333,000USD | -970,944,000USD |
| Accumulated Depreciation | — | — | — | — | — | — | — | -361,030,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD | FY 20182018-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 251,566,000USD | 136,777,000USD | 93,358,000USD | 310,991,000USD | 70,027,000USD | -85,334,000USD | 95,168,000USD | 33,769,000USD |
| Depreciation | 55,120,000USD | 113,624,000USD | 160,214,000USD | 229,250,000USD | 87,196,000USD | 86,625,000USD | 42,272,000USD | 41,778,000USD |
| Stock Based Compensation | 41,216,000USD | 25,947,000USD | 14,299,000USD | 22,611,000USD | 12,824,000USD | 13,878,000USD | 13,217,000USD | 14,499,000USD |
| Deferred Income Tax | 68,352,000USD | — | — | — | — | — | — | — |
| Other Non Cash Items | 75,397,000USD | 131,292,000USD | 58,381,000USD | -414,419,000USD | 45,724,000USD | 190,212,000USD | 90,761,000USD | 139,835,000USD |
| Change To Account Receivables | -89,263,000USD | -76,355,000USD | -56,309,000USD | -41,391,000USD | 15,443,000USD | -11,392,000USD | -21,123,000USD | -13,911,000USD |
| Change To Liabilities | -3,505,000USD | — | 12,031,000USD | 19,778,000USD | 17,638,000USD | -10,999,000USD | 5,561,000USD | 8,408,000USD |
| Change In Working Capital | -21,229,000USD | -111,865,000USD | -134,338,000USD | -137,832,000USD | -23,572,000USD | -97,689,000USD | -36,560,000USD | 9,308,000USD |
| Operating Cash Flow | 470,422,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -77,696,000USD | -48,893,000USD | -26,014,000USD | -31,054,000USD | -39,881,000USD | -39,605,000USD | -57,574,000USD | -46,622,000USD |
| Net Investments | -1,004,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -5,000,000USD | 47,850,000USD | -52,927,000USD | -1,498,054,000USD | 8,024,000USD | -110,537,000USD | -103,929,000USD | -2,910,000USD |
| Investing Cash Flow | -83,700,000USD | — | — | — | — | — | — | — |
| Net Debt Issuance | 112,167,000USD | — | — | — | — | — | — | — |
| Common Stock Issuance | 1,790,000USD | — | — | — | — | — | — | — |
| Net Common Stock Issuance | -282,233,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -11,856,000USD | — | 16,395,000USD | 88,967,000USD | — | 3,778,000USD | 19,710,000USD | 21,284,000USD |
| Financing Cash Flow | -180,132,000USD | — | — | — | — | — | — | — |
| Change In Cash | 206,590,000USD | -53,873,000USD | -72,862,000USD | -965,679,000USD | 812,511,000USD | 200,638,000USD | -143,938,000USD | 193,309,000USD |
| End Cash Flow | 407,754,000USD | — | — | — | — | — | — | — |
| Total Cash From Operating Activities | — | 295,775,000USD | 191,914,000USD | 10,601,000USD | 192,199,000USD | 107,692,000USD | 204,858,000USD | 239,189,000USD |
| Free Cash Flow | — | 246,881,999USD | 165,899,999USD | -20,452,999USD | 152,318,000USD | 68,086,999USD | 147,284,000USD | 192,567,000USD |
| Investments | — | -47,850,000USD | 52,927,000USD | 10,000,000USD | -8,024,000USD | 110,537,000USD | -14,480,000USD | -159,000USD |
| Total Cashflows From Investing Activities | — | -47,850,000USD | 23,739,000USD | -551,804,000USD | -56,688,000USD | 382,523,000USD | -213,836,000USD | -71,450,000USD |
| Net Borrowings | — | -50,000,000USD | -164,023,000USD | -309,266,000USD | 797,000,000USD | -107,800,000USD | 104,705,000USD | 153,716,000USD |
| Total Cash From Financing Activities | — | -301,798,000USD | -288,515,000USD | -424,476,000USD | 676,466,000USD | -256,108,999USD | -137,533,000USD | 37,204,000USD |
| Sale Purchase Of Stock | — | -269,697,000USD | -127,725,000USD | -122,834,000USD | -104,206,000USD | -142,374,000USD | -259,653,000USD | -141,231,000USD |
| Begin Period Cash Flow | — | 275,075,000USD | 347,937,000USD | 1,313,616,000USD | 501,105,000USD | 300,467,000USD | 444,405,000USD | 251,096,000USD |
| End Period Cash Flow | — | 221,202,000USD | 275,075,000USD | 347,937,000USD | 1,313,616,000USD | 501,105,000USD | 300,467,000USD | 444,405,000USD |
| Other Cashflows From Investing Activities | — | 1,043,000USD | 49,753,000USD | 967,304,000USD | -16,807,000USD | 422,128,000USD | -37,853,000USD | -21,759,000USD |
| Other Cashflows From Financing Activities | — | 17,899,000USD | -9,929,000USD | -71,929,000USD | -16,328,000USD | -5,934,999USD | 15,120,000USD | 3,435,000USD |
| Change To Inventory | — | — | -65,306,000USD | — | -22,629,000USD | -71,642,000USD | -17,849,000USD | 11,855,000USD |
| Dividends Paid | — | — | -3,233,000USD | -9,414,000USD | -1,719,000USD | -3,778,000USD | -17,415,000USD | 0USD |
| Cash And Cash Equivalents Changes | — | — | -72,862,000USD | -965,679,000USD | 811,977,000USD | 234,106,000USD | -143,938,000USD | 193,309,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | 2,573,000USD | -11,634,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 57,982,000USD | 76,376,000USD | 61,832,000USD | 54,212,000USD | 60,832,000USD | 75,856,000USD | 46,165,000USD | 49,419,000USD |
| Depreciation | 20,775,000USD | 22,363,000USD | 21,462,000USD | 21,443,000USD | 27,086,000USD | 21,252,000USD | 20,669,000USD | 26,194,000USD |
| Stock Based Compensation | 9,571,000USD | 13,239,000USD | 8,292,999USD | 10,409,000USD | 10,263,000USD | 11,467,000USD | 9,451,000USD | 6,542,000USD |
| Other Non Cash Items | 22,544,000USD | -122,879,000USD | 178,228,000USD | -7,178,000USD | 119,930,000USD | -122,116,000USD | 127,147,000USD | 19,067,000USD |
| Change To Account Receivables | -29,546,000USD | 15,965,000USD | -62,690,000USD | -207,000USD | -34,120,000USD | 10,310,000USD | -56,803,000USD | -2,694,000USD |
| Change In Working Capital | 67,891,000USD | 40,645,000USD | -139,266,000USD | -19,194,000USD | -10,201,000USD | -5,478,000USD | -114,116,000USD | -40,954,000USD |
| Total Cash From Operating Activities | 186,166,000USD | 29,744,000USD | 130,549,000USD | 59,692,000USD | 207,910,000USD | -19,019,000USD | 89,316,000USD | 60,268,000USD |
| Capital Expenditures | -20,235,000USD | -14,624,000USD | -16,023,000USD | -18,990,000USD | -10,243,000USD | -10,680,000USD | -10,414,000USD | -16,577,000USD |
| Free Cash Flow | 165,931,000USD | 15,120,000USD | 114,526,000USD | 40,702,000USD | 197,667,000USD | -29,698,999USD | 78,902,000USD | 43,691,000USD |
| Investments | 0USD | 1,000USD | -16,023,000USD | -11,656,000USD | -10,049,000USD | -10,681,000USD | -9,535,000USD | 4,036,000USD |
| Total Cashflows From Investing Activities | -20,235,000USD | -19,623,000USD | -16,023,000USD | -11,656,000USD | -10,049,000USD | -10,681,000USD | -9,535,000USD | -15,662,000USD |
| Net Borrowings | -833,000USD | -50,000,000USD | 0USD | 0USD | -100,000,000USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | -75,732,000USD | -217,666,000USD | -49,505,000USD | -68,053,000USD | -172,099,000USD | -41,753,000USD | -34,111,000USD | -10,728,000USD |
| Sale Purchase Of Stock | -67,504,000USD | -167,633,000USD | -46,714,000USD | -68,432,000USD | -72,629,000USD | -42,357,000USD | -43,907,000USD | -12,634,000USD |
| Change In Cash | 90,199,000USD | -207,545,000USD | 65,021,000USD | -20,017,000USD | 25,762,000USD | -71,453,000USD | 45,670,000USD | 33,878,000USD |
| Begin Period Cash Flow | 58,640,000USD | 266,185,000USD | 201,164,000USD | 221,181,000USD | 195,419,000USD | 266,872,000USD | 221,202,000USD | 187,324,000USD |
| End Period Cash Flow | 148,839,000USD | 58,640,000USD | 266,185,000USD | 201,164,000USD | 221,181,000USD | 195,419,000USD | 266,872,000USD | 221,202,000USD |
| Other Cashflows From Financing Activities | -89,000USD | -50,033,000USD | -2,791,000USD | 379,000USD | -99,470,000USD | 604,000USD | 9,796,000USD | 1,906,000USD |
| Unclassified Operating Cash Flow | 7,403,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -7,306,000USD | 50,000,000USD | — | — | 100,000,000USD | — | — | — |
| Other Cashflows From Investing Activities | — | -4,999,000USD | — | 7,334,000USD | 194,000USD | -1,000USD | 879,000USD | 915,000USD |
| Unclassified Investing Cash Flow | — | — | 16,023,000USD | 11,656,000USD | 10,049,000USD | 10,681,000USD | 9,535,000USD | -4,036,000USD |
| Change To Inventory | — | — | — | — | — | — | — | 3,527,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2026Yearly · 2026-06-30 | Geography | Barbados St.Kitts St.Maarten And United Kingdom | 398,940,000 | USD | Disclosure |
| FY 2026Yearly · 2026-06-30 | Geography | Domestic Operations | 1,555,145,000 | USD | Disclosure |
| FY 2026Yearly · 2026-06-30 | Product | Other Services | 8,893,000 | USD | Disclosure |
| FY 2026Yearly · 2026-06-30 | Product | Tuition | 1,945,192,000 | USD | Disclosure |
| FY 2026Yearly · 2026-06-30 | Segment | Chamberlain University | 750,212,000 | USD | Disclosure |
| FY 2026Yearly · 2026-06-30 | Segment | Medical And Veterinary | 398,940,000 | USD | Disclosure |
| FY 2026Yearly · 2026-06-30 | Segment | Walden University | 804,933,000 | USD | Disclosure |
| Q3 2026Quarterly · 2026-03-31 | Geography | Barbados St.Kitts And St.Maarten | 103,492,000 | USD | 0001104659-26-057163 |
| Q3 2026Quarterly · 2026-03-31 | Geography | Domestic Operations | 383,538,000 | USD | 0001104659-26-057163 |
| Q3 2026Quarterly · 2026-03-31 | Product | Other Services | 2,432,000 | USD | 0001104659-26-057163 |
| Q3 2026Quarterly · 2026-03-31 | Product | Tuition | 484,598,000 | USD | 0001104659-26-057163 |
| Q3 2026Quarterly · 2026-03-31 | Segment | Chamberlain University | 196,963,000 | USD | 0001104659-26-057163 |
| Q3 2026Quarterly · 2026-03-31 | Segment | Medical And Veterinary | 103,492,000 | USD | 0001104659-26-057163 |
| Q3 2026Quarterly · 2026-03-31 | Segment | Walden University | 186,575,000 | USD | 0001104659-26-057163 |
| Q2 2026Quarterly · 2025-12-31 | Geography | Barbados St.Kitts And St.Maarten | 101,991,000 | USD | 0001104659-26-007415 |
| Q2 2026Quarterly · 2025-12-31 | Geography | Domestic Operations | 401,394,000 | USD | 0001104659-26-007415 |
| Q2 2026Quarterly · 2025-12-31 | Product | Other Services | 1,631,000 | USD | 0001104659-26-007415 |
| Q2 2026Quarterly · 2025-12-31 | Product | Tuition | 501,754,000 | USD | 0001104659-26-007415 |
| Q2 2026Quarterly · 2025-12-31 | Segment | Chamberlain University | 183,832,000 | USD | 0001104659-26-007415 |
| Q2 2026Quarterly · 2025-12-31 | Segment | Medical And Veterinary | 101,991,000 | USD | 0001104659-26-007415 |
| Q2 2026Quarterly · 2025-12-31 | Segment | Walden University | 217,562,000 | USD | 0001104659-26-007415 |
| Q1 2026Quarterly · 2025-09-30 | Geography | Barbados St.Kitts And St.Maarten | 93,127,000 | USD | 0001104659-25-104397 |
| Q1 2026Quarterly · 2025-09-30 | Geography | Domestic Operations | 369,161,000 | USD | 0001104659-25-104397 |
| Q1 2026Quarterly · 2025-09-30 | Product | Other Services | 2,190,000 | USD | 0001104659-25-104397 |
| Q1 2026Quarterly · 2025-09-30 | Product | Tuition | 460,098,000 | USD | 0001104659-25-104397 |
| Q1 2026Quarterly · 2025-09-30 | Segment | Chamberlain University | 179,201,000 | USD | 0001104659-25-104397 |
| Q1 2026Quarterly · 2025-09-30 | Segment | Medical And Veterinary | 93,127,000 | USD | 0001104659-25-104397 |
| Q1 2026Quarterly · 2025-09-30 | Segment | Walden University | 189,960,000 | USD | 0001104659-25-104397 |
| FY 2025Yearly · 2025-06-30 | Geography | Barbados St.Kitts St.Maarten And United Kingdom | 369,086,000 | USD | Disclosure |
| FY 2025Yearly · 2025-06-30 | Geography | Domestic Operations | 1,419,204,000 | USD | Disclosure |
| FY 2025Yearly · 2025-06-30 | Product | Other Services | 9,873,000 | USD | Disclosure |
| FY 2025Yearly · 2025-06-30 | Product | Tuition | 1,778,417,000 | USD | Disclosure |
| FY 2025Yearly · 2025-06-30 | Segment | Chamberlain University | 725,774,000 | USD | Disclosure |
| FY 2025Yearly · 2025-06-30 | Segment | Medical And Veterinary | 369,086,000 | USD | Disclosure |
| FY 2025Yearly · 2025-06-30 | Segment | Walden University | 693,430,000 | USD | Disclosure |
| Q4 2025Quarterly · 2025-06-30 | Geography | Barbados St.Kitts And St.Maarten | 90,647,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Geography | Domestic Operations | 366,459,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Other Services | 2,039,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Tuition | 455,067,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Segment | Chamberlain University | 184,266,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Segment | Medical And Veterinary | 90,647,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Segment | Walden University | 182,193,000 | USD | Legacy provider |
| Q3 2025Quarterly · 2025-03-31 | Geography | Barbados St.Kitts And St.Maarten | 95,045,000 | USD | 0001104659-26-057163 |
| Q3 2025Quarterly · 2025-03-31 | Geography | Domestic Operations | 371,010,000 | USD | 0001104659-26-057163 |
| Q3 2025Quarterly · 2025-03-31 | Product | Other Services | 2,448,000 | USD | 0001104659-26-057163 |
| Q3 2025Quarterly · 2025-03-31 | Product | Tuition | 463,607,000 | USD | 0001104659-26-057163 |
| Q3 2025Quarterly · 2025-03-31 | Segment | Chamberlain University | 192,592,000 | USD | 0001104659-26-057163 |
| Q3 2025Quarterly · 2025-03-31 | Segment | Medical And Veterinary | 95,045,000 | USD | 0001104659-26-057163 |
| Q3 2025Quarterly · 2025-03-31 | Segment | Walden University | 178,418,000 | USD | 0001104659-26-057163 |
| Q2 2025Quarterly · 2024-12-31 | Geography | Barbados St.Kitts And St.Maarten | 95,437,000 | USD | 0001104659-26-007415 |
| Q2 2025Quarterly · 2024-12-31 | Geography | Domestic Operations | 352,292,000 | USD | 0001104659-26-007415 |
| Q2 2025Quarterly · 2024-12-31 | Product | Other Services | 2,416,000 | USD | 0001104659-26-007415 |
| Q2 2025Quarterly · 2024-12-31 | Product | Tuition | 445,313,000 | USD | 0001104659-26-007415 |
| Q2 2025Quarterly · 2024-12-31 | Segment | Chamberlain University | 180,986,000 | USD | 0001104659-26-007415 |
| Q2 2025Quarterly · 2024-12-31 | Segment | Medical And Veterinary | 95,437,000 | USD | 0001104659-26-007415 |
| Q2 2025Quarterly · 2024-12-31 | Segment | Walden University | 171,306,000 | USD | 0001104659-26-007415 |
| Q1 2025Quarterly · 2024-09-30 | Geography | Barbados St.Kitts And St.Maarten | 87,957,000 | USD | 0001104659-25-104397 |
| Q1 2025Quarterly · 2024-09-30 | Geography | Domestic Operations | 329,443,000 | USD | 0001104659-25-104397 |
| Q1 2025Quarterly · 2024-09-30 | Product | Other Services | 2,970,000 | USD | 0001104659-25-104397 |
| Q1 2025Quarterly · 2024-09-30 | Product | Tuition | 414,430,000 | USD | 0001104659-25-104397 |
| Q1 2025Quarterly · 2024-09-30 | Segment | Chamberlain University | 167,930,000 | USD | 0001104659-25-104397 |
| Q1 2025Quarterly · 2024-09-30 | Segment | Medical And Veterinary | 87,957,000 | USD | 0001104659-25-104397 |
| Q1 2025Quarterly · 2024-09-30 | Segment | Walden University | 161,513,000 | USD | 0001104659-25-104397 |
| FY 2024Yearly · 2024-06-30 | Geography | Barbados St.Kitts St.Maarten And United Kingdom | 355,798,000 | USD | Disclosure |
| FY 2024Yearly · 2024-06-30 | Geography | Domestic Operations | 1,228,854,000 | USD | Disclosure |
| FY 2024Yearly · 2024-06-30 | Product | Other Services | 13,409,000 | USD | Disclosure |
| FY 2024Yearly · 2024-06-30 | Product | Tuition | 1,571,243,000 | USD | Disclosure |
| FY 2024Yearly · 2024-06-30 | Segment | Chamberlain University | 633,522,000 | USD | Disclosure |
| FY 2024Yearly · 2024-06-30 | Segment | Medical And Veterinary | 355,798,000 | USD | Disclosure |
| FY 2024Yearly · 2024-06-30 | Segment | Walden University | 595,332,000 | USD | Disclosure |
| Q4 2024Quarterly · 2024-06-30 | Geography | Barbados St.Kitts And St.Maarten | 86,563,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Geography | Domestic Operations | 323,344,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Product | Other Services | 3,040,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Product | Tuition | 406,867,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Segment | Chamberlain University | 167,035,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Segment | Medical And Veterinary | 86,563,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Segment | Walden University | 156,309,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-06-30 | Geography | Barbados St.Kitts And St.Maarten | 346,067,000 | USD | 0001558370-25-010780 |
| FY 2023Yearly · 2023-06-30 | Geography | Domestic Operations | 1,104,759,000 | USD | 0001558370-25-010780 |
| FY 2023Yearly · 2023-06-30 | Product | Other Services | 11,744,000 | USD | 0001558370-25-010780 |
| FY 2023Yearly · 2023-06-30 | Product | Tuition | 1,439,082,000 | USD | 0001558370-25-010780 |
| FY 2023Yearly · 2023-06-30 | Segment | Chamberlain University | 571,034,000 | USD | 0001558370-25-010780 |
| FY 2023Yearly · 2023-06-30 | Segment | Medical And Veterinary | 346,067,000 | USD | 0001558370-25-010780 |
| FY 2023Yearly · 2023-06-30 | Segment | Walden University | 533,725,000 | USD | 0001558370-25-010780 |
| FY 2022Yearly · 2022-06-30 | Geography | Barbados St.Kitts And St.Maarten | 338,913,000 | USD | 0001558370-24-011099 |
| FY 2022Yearly · 2022-06-30 | Geography | Domestic Operations | 1,042,929,000 | USD | 0001558370-24-011099 |
| FY 2022Yearly · 2022-06-30 | Product | Other Services | 10,531,000 | USD | 0001558370-24-011099 |
| FY 2022Yearly · 2022-06-30 | Product | Tuition | 1,371,311,000 | USD | 0001558370-24-011099 |
| FY 2022Yearly · 2022-06-30 | Segment | Chamberlain University | 557,536,000 | USD | 0001558370-24-011099 |
| FY 2022Yearly · 2022-06-30 | Segment | Medical And Veterinary | 338,913,000 | USD | 0001558370-24-011099 |
| FY 2022Yearly · 2022-06-30 | Segment | Walden University | 485,393,000 | USD | 0001558370-24-011099 |
| FY 2021Yearly · 2021-06-30 | Geography | Barbados St.Kitts And St.Maarten | 335,434,000 | USD | 0001558370-23-014509 |
| FY 2021Yearly · 2021-06-30 | Geography | Domestic Operations | 563,814,000 | USD | 0001558370-23-014509 |
| FY 2021Yearly · 2021-06-30 | Product | Other Services | 3,275,000 | USD | 0001558370-23-014509 |
| FY 2021Yearly · 2021-06-30 | Product | Tuition | 895,973,000 | USD | 0001558370-23-014509 |
| FY 2021Yearly · 2021-06-30 | Segment | Chamberlain University | 563,814,000 | USD | 0001558370-23-014509 |
| FY 2021Yearly · 2021-06-30 | Segment | Medical And Veterinary | 335,434,000 | USD | 0001558370-23-014509 |
| FY 2021Yearly · 2021-06-30 | Segment | Walden University | 0 | USD | 0001558370-23-014509 |
| FY 2020Yearly · 2020-06-30 | Geography | Barbados St.Kitts And St.Maarten | 354,772,000 | USD | 0001558370-22-013289 |
| FY 2020Yearly · 2020-06-30 | Geography | Domestic Operations | 511,655,000 | USD | 0001558370-22-013289 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.